CULLEN MICHAEL T. (Exec. Chairman, Pres. & CEO) purchased 5.1% of their position (10K shares) of PANBELA THERAPEUTICS, INC. on the open market
Open‑market purchases signal personal conviction — classified as a moderate purchase.
P · 1 purchase
Filed: 9/1/2020ACC: 0001437749-20-019142
DirectorOfficer10% Owner· Exec. Chairman, Pres. & CEO
Since Dec 2018
+20K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
—
Trade value
—
% of position
5.1%
9/1/2020
198K→208K
Total
Net shares
+10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2020 | P · Purchase | +10K | — | — | 5.1% | 198K | 208K |
| Total | +10K | $0.00 | ||||||
Derivative Transactions1
Warrant (right to buy)
Direct
Converts to
Common Stock
10K shares
Shares
+10K
Strike price
4.54
Held after
10K
Exercisable
—
9/1/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (right to buy) Direct | Common Stock10K shares | 9/1/2020 | P · Purchase | +10K | 4.54 | — | 10K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned204.58K
Total
204.58K indirect204.58K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 204.58K | Indirect |
| Total | 204.58K | 204.58K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported